These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 17585704)

  • 21. Emergence of vancomycin-intermediate Staphylococcus species in southern India.
    Menezes GA; Harish BN; Sujatha S; Vinothini K; Parija SC
    J Med Microbiol; 2008 Jul; 57(Pt 7):911-912. PubMed ID: 18566156
    [No Abstract]   [Full Text] [Related]  

  • 22. Tolerance to the glycopeptides vancomycin and teicoplanin in coagulase-negative staphylococci.
    Bourgeois I; Pestel-Caron M; Lemeland JF; Pons JL; Caron F
    Antimicrob Agents Chemother; 2007 Feb; 51(2):740-3. PubMed ID: 17116684
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reduced glycopeptide susceptibility in methicillin-resistant Staphylococcus aureus (MRSA).
    Appelbaum PC
    Int J Antimicrob Agents; 2007 Nov; 30(5):398-408. PubMed ID: 17888634
    [TBL] [Abstract][Full Text] [Related]  

  • 24. First report in Spain of linezolid non-susceptibility in a clinical isolate of Staphylococcus haemolyticus.
    Tarazona RE; Padilla TP; Gómez JC; Sánchez JE; Hernandez MS
    Int J Antimicrob Agents; 2007 Sep; 30(3):277-8. PubMed ID: 17600688
    [No Abstract]   [Full Text] [Related]  

  • 25. Teicoplanin resistance in Staphylococcus haemolyticus is associated with mutations in histidine kinases VraS and WalK.
    Vimberg V; Cavanagh JP; Benada O; Kofroňová O; Hjerde E; Zieglerová L; Balíková Novotná G
    Diagn Microbiol Infect Dis; 2018 Mar; 90(3):233-240. PubMed ID: 29246777
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vancomycin resistance: are there better glycopeptides coming?
    Linden PK
    Expert Rev Anti Infect Ther; 2008 Dec; 6(6):917-28. PubMed ID: 19053904
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Selection of a surrogate agent (vancomycin or teicoplanin) for initial susceptibility testing of dalbavancin: results from an international antimicrobial surveillance program.
    Jones RN; Sader HS; Fritsche TR; Hogan PA; Sheehan DJ
    J Clin Microbiol; 2006 Jul; 44(7):2622-5. PubMed ID: 16825398
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High in vitro antimicrobial activity of synthetic antimicrobial peptidomimetics against staphylococcal biofilms.
    Flemming K; Klingenberg C; Cavanagh JP; Sletteng M; Stensen W; Svendsen JS; Flaegstad T
    J Antimicrob Chemother; 2009 Jan; 63(1):136-45. PubMed ID: 19010828
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of method-specific vancomycin minimum inhibitory concentration values and their predictability for treatment outcome of meticillin-resistant Staphylococcus aureus (MRSA) infections.
    Hsu DI; Hidayat LK; Quist R; Hindler J; Karlsson A; Yusof A; Wong-Beringer A
    Int J Antimicrob Agents; 2008 Nov; 32(5):378-85. PubMed ID: 18701261
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro activity of omiganan pentahydrochloride tested against vancomycin-tolerant, -intermediate, and -resistant Staphylococcus aureus.
    Fritsche TR; Rhomberg PR; Sader HS; Jones RN
    Diagn Microbiol Infect Dis; 2008 Apr; 60(4):399-403. PubMed ID: 18178361
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacodynamic comparison of linezolid, teicoplanin and vancomycin against clinical isolates of Staphylococcus aureus and coagulase-negative staphylococci collected from hospitals in Brazil.
    Kuti JL; Kiffer CR; Mendes CM; Nicolau DP
    Clin Microbiol Infect; 2008 Feb; 14(2):116-23. PubMed ID: 18076672
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Constitutive and inducible clindamycin resistance among nosocomially acquired staphylococci].
    Dizbay M; Günal O; Ozkan Y; Ozcan Kanat D; Altunçekiç A; Arman D
    Mikrobiyol Bul; 2008 Apr; 42(2):217-21. PubMed ID: 18697419
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antimicrobial susceptibility of Gram-positive bacteria isolated from US medical centers: results of the Daptomycin Surveillance Program (2007-2008).
    Sader HS; Jones RN
    Diagn Microbiol Infect Dis; 2009 Oct; 65(2):158-62. PubMed ID: 19748426
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multiplex PCR assay to identify methicillin-resistant Staphylococcus haemolyticus.
    Schuenck RP; Pereira EM; Iorio NL; Dos Santos KR
    FEMS Immunol Med Microbiol; 2008 Apr; 52(3):431-5. PubMed ID: 18294192
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multicenter evaluation of the in vitro activity of dalbavancin tested against staphylococci and streptococci in 5 European countries: results from the DECIDE Surveillance Program (2007).
    Biedenbach DJ; Jones RN
    Diagn Microbiol Infect Dis; 2009 Jun; 64(2):177-84. PubMed ID: 19249179
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Comparison of induction L-form of Staphylococcus epidermidis, Staphylococcus haemolyticus by cefazolin].
    Wróblewska J; Gospodarek E; Sekowska A; Mikołajczyk D; Janicka G
    Pol Merkur Lekarski; 2008 Dec; 25(150):500-2. PubMed ID: 19205381
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of vancomycin and daptomycin against methicillin-resistant Staphylococcus aureus and heterogeneously vancomycin-intermediate S. aureus in an in vitro pharmacokinetic/pharmacodynamic model with simulated endocardial vegetations.
    Leonard SN; Rybak MJ
    J Antimicrob Chemother; 2009 Jan; 63(1):155-60. PubMed ID: 18984644
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The rate of inducible clindamycin resistance and susceptibilities to other antimicrobial agents in staphylococci].
    Oğuz VA; Yapar N; Sezak N; Cavuş SA; Kurutepe S; Peksel H; Cakir N; Yüce A
    Mikrobiyol Bul; 2009 Jan; 43(1):37-44. PubMed ID: 19334378
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Variable number of tandem repeat profiles and antimicrobial resistance patterns of Staphylococcus haemolyticus strains isolated from blood cultures in children.
    Hosseinkhani F; Jabalameli F; Nodeh Farahani N; Taherikalani M; van Leeuwen WB; Emaneini M
    Infect Genet Evol; 2016 Mar; 38():19-21. PubMed ID: 26656742
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nosocomial outbreak of vancomycin-resistant Enterococcus faecium in a paediatric unit at a Turkish university hospital.
    Ergani-Ozcan A; Naas T; Baysan BO; Ogunc D; Inan D; Colak D; Nordmann P
    J Antimicrob Chemother; 2008 May; 61(5):1033-9. PubMed ID: 18319236
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.